Overview

Investigation of the Drug Dimethoxbenzylidene Anabaseine in Treating Schizophrenia Patients

Status:
Completed

Trial end date:
2005-10-01

Target enrollment:

Participant gender:

Summary

This study will determine the effectiveness of a drug, dimethoxbenzylidene anabaseine, in producing beneficial effects similar to that of nicotine in individuals with schizophrenia.

Phase:

Phase 1

Details

Lead Sponsor:

University of Colorado, Denver

Collaborator:

National Institute of Mental Health (NIMH)

Treatments:

3-(2,4-dimethoxybenzylidene)anabaseine